Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Apr 28, 2012; 18(16): 1884-1891
Published online Apr 28, 2012. doi: 10.3748/wjg.v18.i16.1884
Published online Apr 28, 2012. doi: 10.3748/wjg.v18.i16.1884
Antithrombin III injection via the portal vein suppresses liver damage
Masayuki Miyazaki, Masaki Kato, Masatake Tanaka, Kosuke Tanaka, Shinichiro Takao, Motoyuki Kohjima, Tetsuhide Ito, Munechika Enjoji, Makoto Nakamuta, Kazuhiro Kotoh, Ryoichi Takayanagi, Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan
Motoyuki Kohjima, Makoto Nakamuta, Department of Gastroenterology, Kyushu Medical Center, National Hospital Organization, Fukuoka 810-0065, Japan
Munechika Enjoji, Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka 814-0180, Japan
Author contributions: Miyazaki M and Kato M performed the majority of experiments and wrote the paper; Tanaka M, Tanaka K, Takao S and Kohjima M supported the experiments; Ito T, Enjoji M, Nakamuta M and Kotoh K analyzed the data; Takayanagi R supervised writing of the paper.
Correspondence to: Masayuki Miyazaki, MD, Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan. mmasayuk@intmed3.med.kyushu-u.ac.jp
Telephone: +81-92-6425282 Fax: +81-92-6425287
Received: August 3, 2011
Revised: December 20, 2011
Accepted: December 31, 2011
Published online: April 28, 2012
Revised: December 20, 2011
Accepted: December 31, 2011
Published online: April 28, 2012
Core Tip